Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? (Q34205488)

31 July 2017

Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits? (English)

1 reference

pancreatic adenocarcinoma

31 July 2017

0 references

1 reference

1 reference

12

Charles R Scoggins

1 reference

31 July 2017

13

Robert C G Martin

1 reference

31 July 2017

Nipun B Merchant

1

1 reference

31 July 2017

Jennifer Rymer

2

1 reference

31 July 2017

Elizabeth A S Koehler

3

1 reference

31 July 2017

G Daniel Ayers

4

1 reference

31 July 2017

Jason Castellanos

5

1 reference

31 July 2017

David A Kooby

6

1 reference

31 July 2017

Sharon H Weber

7

1 reference

31 July 2017

Clifford S Cho

8

1 reference

31 July 2017

C Max Schmidt

9

1 reference

31 July 2017

Atilla Nakeeb

10

1 reference

31 July 2017

Jesus M Matos

11

1 reference

31 July 2017

Hong Jin Kim

14

1 reference

31 July 2017

Syed A Ahmad

15

1 reference

31 July 2017

Carrie K Chu

16

1 reference

31 July 2017

Rebecca McClaine

17

1 reference

31 July 2017

Brian K Bednarski

18

1 reference

31 July 2017

Charles A Staley

19

1 reference

31 July 2017

Kenneth Sharp

20

1 reference

31 July 2017

Alexander A Parikh

21

1 reference

31 July 2017

26 March 2009

1 reference

Journal of the American College of Surgeons

31 July 2017

1 reference

31 July 2017

208

1 reference

31 July 2017

5

1 reference

31 July 2017

829-38; discussion 838-41

1 reference

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

One thousand consecutive pancreaticoduodenectomies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

28 July 2018

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Adjuvant treatment for resectable pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Prognostic indicators for survival after resection of pancreatic adenocarcinoma.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4167601

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19476845

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JAMCOLLSURG.2008.12.020

1 reference

31 July 2017

1 reference

31 July 2017

1 reference